NASDAQ:OPGN - OpGen, Inc.
$0.33
 $-0.01
-2.37%
12:05PM EDT
2019-07-22
OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  OPGN     avg for
industry  
  avg for
sector  
42 stocks weight:  6. 60   217. 37   399. 45  
42 stocks rank:  4. 08 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  1. 25   5. 49   1. 88  
current ratio:  1. 36   5. 87   2. 36  

target price low:  0. 70   83. 44   114. 90  
target price avg:  0. 52   106. 20   137. 90  
target price high:  0. 32   132. 30   158. 97  
1-yr high:  2. 20   111. 86   142. 57  
last close:  0. 34   86. 79   125. 44  
50-day avg:  0. 42   86. 68   122. 63  
200-day avg:  1. 00   89. 22   121. 38  
1-yr low:  0. 32   69. 78   100. 51  
volume:  101. 46 K 2. 62 M 3. 43 M
50-day avg volume:  553. 95 K 3. 20 M 4. 16 M
200-day avg volume:  294. 55 K 2. 99 M 4. 75 M

1-day return:  2. 71 % -1. 30 % -0. 99 %
this week return:  -6. 14 % 0. 45 % -0. 20 %
12-wk return:  -36. 48 % 0. 94 % 4. 84 %
52-wk return:  -83. 70 % -1. 30 % 10. 55 %

enterprise value (EV):  3. 99 M 45. 10 B 122. 38 B
market cap:  5. 96 M 38. 96 B 108. 40 B
EBITDA:  -12. 61 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 32   5. 38   11. 93  
enterprise/revenue (EV/R):  1. 28   57. 92   10. 21  
total revenue:  3. 12 M 9. 91 B 39. 98 B
total debt:  4. 04 M 10. 90 B 17. 48 B
debt/equity:  93. 11   57. 18   120. 05  
net income (common):  -14. 17 M 2. 07 B 4. 05 B

shares outstanding:  2. 26 M 538. 09 M 1. 24 B
shares:  16. 64 M 548. 00 M 1. 22 B
shares short:  128. 58 K 10. 98 M 11. 87 M
shares short prior month:  144. 04 K 9. 32 M 12. 05 M
short ratio:  0. 13   5. 60   3. 34  
short % of float:  1. 60 % 6. 48 % 2. 64 %
total cash/share:  0. 34   10. 98   9. 19  
total cash:  6. 01 M 5. 93 B 6. 10 B
free cash flow:  -7. 13 M 2. 92 B 4. 55 B
operating cash flow:  -11. 83 M 3. 80 B 5. 78 B

book value:  0. 25   13. 35   27. 45  
price/book:  1. 37   4. 60   8. 78  
gross profits:  -4. 58 M 7. 44 B 36. 13 B
operating margins:  -429. 63 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  -154. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 93   2. 10   4. 23  
forward EPS:  -0. 55   3. 45   7. 10  
P/E:  -0. 17   1. 90   32. 10  
forward P/E:  -0. 61   6. 46   15. 47  
PE/G:  -0. 01   0. 70   -0. 54  
growth:  20. 60 % 265. 63 % 79. 11 %
earnings high:  -0. 16   0. 89   1. 68  
earnings avg:  -0. 17   0. 70   1. 57  
earnings low:  -0. 19   0. 46   1. 46  
revenue high:  1. 05 M 2. 57 B 11. 07 B
revenue avg:  1. 02 M 2. 51 B 10. 91 B
revenue low:  1000. 00 K 2. 45 B 10. 73 B
return on assets:  -62. 75 % -2. 34 % 5. 28 %
return on equity:  -207. 83 % -90. 08 % 133. 53 %
revenue growth:  20. 60 % 265. 25 % 73. 68 %
revenue/share:  0. 43   12. 72   60. 04  

beta (1yr vs S&P500):  0. 33   1. 27   0. 91  
sharpe (1yr):  -1. 71   0. 16   0. 77  

held % insiders:  2. 17 % 6. 06 % 3. 29 %
held % institutions:  10. 53 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : OPGN
.    100.708 =       100.708 :: --> INITIAL WEIGHT <--
.    - 1.933 =        98.775 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.942 =       191.786 :: P/E factor
.    x 2.209 =       423.647 :: PE/G factor
.    x 1.559 =       660.491 :: beta factor
.    x 0.761 =       502.627 :: sharpe factor
.    x 2.233 =      1122.174 :: current ratio factor
.    x 1.738 =       1950.23 :: quick ratio factor
.     x 2.14 =      4174.442 :: short ratio factor
.    x 1.373 =      5730.307 :: revenue growth factor
.    x 1.022 =      5856.836 :: EV/R factor
.    x 1.007 =      5896.923 :: price-to-book factor
.    x 0.917 =      5409.075 :: debt-to-revenue factor
.    x 1.171 =      6335.071 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     13435.373 :: sector+industry 1-year gains factor
.    x 1.009 =     13562.043 :: industry 12-weeks return factor
.    x 1.308 =     17737.641 :: industry 2-weeks return factor
.     x 0.97 =     17204.507 :: "drift" penalty 2 days ago
.    / 2.089 =      8236.566 :: overall "drift" factor
.    x 0.741 =       6103.43 :: largest single-day jump factor
.    x 0.059 =       362.391 :: low price factor
.    x 0.368 =       133.214 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.303 =        40.297 :: forward EPS factor
.    x 0.747 =        30.083 :: forward P/E factor
.    x 1.185 =         35.64 :: industry recommendation factor
.    x 2.142 =        76.327 :: company recommendation factor
.    x 1.003 =        76.538 :: factor historical industry gain for week 29
.    x 9.601 =       734.817 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         5.206 :: reduced for readability
.    + 1.389 =         6.596 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      6.596 :: FINAL WEIGHT for NASDAQ:OPGN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org